Download presentation
Presentation is loading. Please wait.
Published byOddbjørn Haaland Modified over 6 years ago
1
Preoperative Serum Soluble Receptor Activator of Nuclear Factor-κB Ligand and Osteoprotegerin Predict Postoperative Atrial Fibrillation in Patients Undergoing Cardiac Valve Surgery Hailong Cao, MD, PhD, Qing Zhou, MD, Yanhu Wu, MD, Qingguo Li, MD, PhD, Oluf Dimitri Røe, MD, PhD, Yijiang Chen, MD, PhD, Zhong Wu, MD, PhD, Dongjin Wang, MD, PhD The Annals of Thoracic Surgery Volume 96, Issue 3, Pages (September 2013) DOI: /j.athoracsur Copyright © 2013 The Society of Thoracic Surgeons Terms and Conditions
2
Fig 1 Box plots illustrating median serum levels of (A) soluble receptor activator of nuclear factor-κB ligand (sRANKL), (B) osteoprotegerin, and (C) sRANKL/osteoprotegerin (OPG) ratios in atrial fibrillation (AF) and sinus rhythm (SR) groups. Boxes show interquartile ranges, and bars represent the 10th and 90th percentiles. The Annals of Thoracic Surgery , DOI: ( /j.athoracsur ) Copyright © 2013 The Society of Thoracic Surgeons Terms and Conditions
3
Fig 2 Kaplan-Meier survival curves showing freedom from postoperative atrial fibrillation (AF) by (A) serum soluble receptor activator of nuclear factor-κB ligand (sRANKL) levels, and (B) sRANKL/osteoprotegerin (OPG) ratio in patients receiving valvular surgery. The Annals of Thoracic Surgery , DOI: ( /j.athoracsur ) Copyright © 2013 The Society of Thoracic Surgeons Terms and Conditions
Similar presentations
© 2024 SlidePlayer.com. Inc.
All rights reserved.